Unknown OBSERVATIONAL NCT06073509

Atrial Fibrillation and Other Cardiac Arrhythmias and Diseases After Radiotherapy for Breast Cancer : Watch Your HeaRT (WATCH)

Watch Your HeaRT Study - Screening and Risk Analysis of Atrial Fibrillation and Other Cardiac Arrhythmias and Diseases After Radiotherapy for Breast Cancer

Sponsor: Centre Francois Baclesse

Conditions Atrial Fibrillation Breast Cancer Cardiac Arrhythmia Cardiac Disease Radiation Toxicity

Interventions Screening for atrial fibrillation and other cardiac arrhythmias and diseases

Updated 5 times since 2023 Last updated: Nov 6, 2023 Started: Oct 25, 2023 Primary completion: Oct 20, 2025 Completion: Nov 20, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Atrial Fibrillation and Breast Cancer and is currently ongoing. Centre Francois Baclesse leads this study, which shows 5 recorded versions since 2023 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Jan 2026 — Present [monthly]

Unknown

Status: Recruiting → Unknown
Sep 2024 — Jan 2026 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Dec 2023 — Jul 2024 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Nov 2023 — Dec 2023 [monthly]

Not Yet Recruiting

First recorded

Oct 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Francois Baclesse
Clinique Pasteur Toulouse
Institut Curie
Sophie JACOB

Data source: Institut de Radioprotection et de Surete Nucleaire

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Toulouse, France